The APO-go pen is a ready-loaded, disposable pen, supplied by the pharmaceutical company Britannia. It can be used for multiple doses, whenever you start feeling an "off" period starting. Your specialist will work out the best dose for you.

Jan 18, 2023 · APO-go® Pen and Dacepton® are for injections which are given intermittently throughout the day, whereas APO-go® PFS are for when apomorphine is being given as a continuous infusion through a syringe driver.

Jul 24, 2024 · APO-go Pen 10 mg/ml is a disposable multiple dose pen injector system incorporating a clear glass (type I) cartridge containing a clear solution for injection. The glass cartridge is sealed at one end with a bromobutyl rubber piston, and at the other end with a bromobutyl rubber/aluminium membrane.

Dec 21, 2020 · APO-go PEN is a non-refillable pen that contains several doses. The pen contains a clear glass syringe with apomorphine solution for injection. The solution is clear, practically colorless, odorless, and free of visible particles.

Apomorphine is a potent injectable dopamine agonist and an effective therapy for patients with Parkinson's who experience disabling motor fluctuations which persist despite individually titrated treatment with levodopa and / or other dopamine agonists.

APO-go Pen is a disposable multiple dose Pen injector system with a clear glass cartridge containing the apomorphine solution for injection. The solution is clear, practically colourless, odourless and free from visible particles.

APO-go Pen 10 mg/ml is a disposable multiple dose pen injector system incorporating a clear glass (type I) cartridge containing a clear solution for injection. The glass cartridge is sealed at one end with a bromobutyl rubber piston, and at the other end with a bromobutyl rubber/aluminium membrane.

APO-go Pen 10mg/ml Solution for Injection - Patient Information Leaflet (PIL) by Britannia Pharmaceuticals Limited

APO-go Pen is used to treat Parkinson’s disease. Apomorphine helps to reduce the amount of time spent in an “off” or immobile state in people who have been previously treated for Parkinson’s disease with levodopa and/or other dopamine agonists.

Apo-Go is available in two forms of administration suitable for different stages of Parkinson's disease, a pen-shaped syringe or a pump. 1. pen - could fit to: - Patients who have a delayed response to their levodopa doses in the morning or during the day, those who wait more than 30 minutes for a response